DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment


More Industry Headlines

PET/CT, PET/MR and PET Product Showcase A quick look at all the leading modalities in the market

Philips gets FDA nod to market IntelliSpace Portal 9.0 and new applications Helps quantify and quickly diagnose conditions

Solutions for mitigating health care investigation complexities and risks Shifting from reactive to proactive to reduce breaches

This microscope could spare women repeat breast cancer surgeries Light-sheet microscope can scan excised breast tissue for cancer cells in 30 minutes

Sanford Health, Mid Dakota merger heads to court Would create a group with at least a 75 percent share of physician services

How fast will the U.S. market get access to Gallium-68? The nuclear medicine world is preparing for the introduction of Ga-68 tracers

German researchers find sweet alternative to conventional MR contrast agents Imaging with glucose using 7T MR scanner

Supplemental breast MR superior to ultrasound for screening breast cancer survivors But what about cost-effectiveness?

Purchasing insights: Molecular imaging modalities will grow in the coming years What to look for when your facility is investing in new systems

Siemens $300 million Walpole groundbreaking set for June 30 Expanding a key manufacturing and R&D facility

Dr. Neal F. Kassell

Focused ultrasound's first North American pediatric patient

by Gus Iversen , Editor in Chief
On July 17th the Focused Ultrasound Foundation and the Hospital for Sick Children (SickKids) at Sunnybrook Health Sciences Center in Toronto, teamed up to treat a 16 year old male suffering from osteoid osteoma — a benign bone tumor in his leg. The patient became the first North American pediatric patient ever to receive high-intensity focused ultrasound (HIFU), and has recovered with no reported complications to date.

Osteoid osteoma occurs most commonly in males 10 to 35 years of age, but has been reported in patients as young as seven months. Despite its small size — about one centimeter — the tumor is known to cause extreme pain, and treatment itself has historically been a painful process with a drawn out recovery.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit to set up an order today.

Until the mid-90s, physicians would typically scrape the tumor from the bone or else remove the affected part of the bone entirely. Since then, radiofrequency or laser energy has been standard to burn the tumor away with the assistance of CT guidance.

Although comparably less invasive, that process may leave patients susceptible to radiation exposure, infection, burning of the surrounding tissue, and bone fractures resulting from the hole remaining after treatment.

HIFU therapy represents a virtually non-invasive alternative to the traditional courses of treatment. With the guidance of MR, HIFU utilizes sound waves to heat an area the size of a grain of rice and destroy the tumor.

It leaves the skin and surrounding bone entirely intact and, consequently, the risk of infection is greatly diminished. The use of MR rather than CT means the patient also avoids radiation exposure.

SickKids reports that the patient was discharged a few hours after the procedure and pain free within a few hours more.

"This is one of those pathfinder indications where it truly is superior to the best current therapy," Dr. Neal F. Kassell, the founder and chairman of the Focused Ultrasound Foundation, told DOTmed News. His foundation is currently funding numerous other clinical trials as well.

Although the procedure itself took 30 minutes, it required about three hours of preparation, which involved general anesthesia and precise placement of the patient on the table, which was equipped with a built-in, high-intensity focused ultrasound transducer manufactured by the Royal Philips Co. The MR enabled physicians to monitor the temperature induced by the ultrasound and ensure that there was no unexpected increase in heat in surrounding tissues.

The bone tumor treatment project is an initiative of the SickKids' Centre for Image-Guided Innovation and Therapeutic Intervention — a research program that brings together surgeons, radiologists, software developers and engineers to develop innovative technologies in robotic and minimally-invasive surgery.

"There will ultimately be twenty patients treated in this trial," said Kassell. "The first was the one that was reported, and that was one of 10 at the University of Toronto. By year end we hope to start in two other centers." Kassell intends to conduct those treatments in the U.S. and is currently seeking approval from the FDA.

HIFU therapy is available in pediatric and adult centers in Europe, and was first performed on patients with osteoid osteoma in Italy in 2010. In North America, the treatment is used on adult patients with uterine fibroids and bone metastases.


You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.